Skip to main content
Clinical Trials/CTRI/2018/02/011832
CTRI/2018/02/011832Recruiting未知

Comparison of post cataract surgery visual outcomes in patients bilaterally implanted with Eyecryl ACTV Diffractive Multifocal IOL & AcrySof® IQ ReSTOR® Multifocal IO

Biotech Vision Care Pvt Ltd0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Patients who has been implanted bilaterally with any one of the Multifocal IOL: Eyecryl ACTV Diffractive Multifocal IOL OR AcrySof® IQ ReSTOR® multifocal IOL will be included in the study.
  • Age 18 and older
  • Regular corneal topography and corneal astigmatism
  • Preoperative & postoperative corneal astigmatism of <= 0.75D
  • Clear intraocular media
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Written informed consent for participation in the study and data protection

Exclusion Criteria

  • Patients with best corrected vision less than 6/9 and or N/6
  • Pupil Size: > 5 mm scotopic size
  • Previous ocular surgery.
  • Any active ocular disease (Diabetic retinopathy, macular degeneration, glaucoma with field defects and irregular corneal astigmatism)
  • Any ocular pathology (corneal, retinal)
  • Subject who are professional Pilots/truck/Car Drivers

Investigators

Sponsor
Biotech Vision Care Pvt Ltd

Similar Trials